
Johnson & Johnson Targets $4 Billion Sale of Diabetes Care Business to Chinese Buyers
Johnson & Johnson is trying to sell its diabetes care business to Chinese buyers for up to US$4 billion, Business Wires News,Chinese bidders are circling a diabetes care business owned by the world's largest healthcare company Johnson & Johnson in a deal that could fetch up to US$4 billion (S$5